Waldenstrom Macroglobulinemia: Tailoring Therapy for the Individual.
Gertz MA.
J Clin Oncol. 2022 Aug 10;40(23):2600-2608. doi: 10.1200/JCO.22.00495. Epub 2022 Jun 14.
How to manage waldenstrom's macroglobulinemia in 2024.
Grunenberg A, Buske C.
Cancer Treat Rev. 2024 Apr;125:102715. doi: 10.1016/j.ctrv.2024.102715. Epub 2024 Mar 5.
The epidemiology of Waldenstrom macroglobulinemia.
McMaster ML.
Semin Hematol. 2023 Mar;60(2):65-72. doi: 10.1053/j.seminhematol.2023.03.008. Epub 2023 Mar 31.
Waldenstrom macroglobulinemia.
Vijay A, Gertz MA.
Blood. 2007 Jun 15;109(12):5096-103. doi: 10.1182/blood-2006-11-055012. Epub 2007 Feb 15.
Waldenstrom's macroglobulinemia.
Dimopoulos MA, Anagnostopoulos A.
Best Pract Res Clin Haematol. 2005;18(4):747-65. doi: 10.1016/j.beha.2005.01.028.
Waldenstrom's macroglobulinemia.
Singhal N, Bapsy PP, Babu KG, Sahoo TP.
J Assoc Physicians India. 2004 Dec;52:981-5.
Waldenstrom's macroglobulinemia.
Dimopoulos MA, Galani E, Matsouka C.
Hematol Oncol Clin North Am. 1999 Dec;13(6):1351-66. doi: 10.1016/s0889-8588(05)70130-1.
Waldenstrom's macroglobulinemia.
Gertz MA, Fonseca R, Rajkumar SV.
Oncologist. 2000;5(1):63-7. doi: 10.1634/theoncologist.5-1-63.
Waldenstrom macroglobulinemia.
Kasi PM, Ansell SM, Gertz MA.
Clin Adv Hematol Oncol. 2015 Jan;13(1):56-66.
Monoclonal Antibodies for Waldenstrom Macroglobulinemia.
Dominguez A, Kastritis E, Castillo JJ.
Hematol Oncol Clin North Am. 2018 Oct;32(5):841-852. doi: 10.1016/j.hoc.2018.05.010. Epub 2018 Jul 21.
